As the general public has shown increased interest in ancestry, companies have responded with at-home ancestry kits, software, and databases. At the same time, scientists continue to work in the area of genetics looking at a person’s genetic markers and how these markers provide clues to a patient’s likelihood of getting particular diseases (including COVID-19), or how they might respond to different drug therapies. How can all of this data help you as a patient?
Dr. David Rawlins, former pharmaceutical drug researcher and faculty in Roseman’s College of Pharmacy presents a life’s worth of experience in research to our guests and sheds light on how our DNA offers insights to our health outcomes.
source
